Table 1.
Baseline characteristics of 266 opioid-dependent patients initiating buprenorphine treatment
| Patient Characteristic | N (%) |
|---|---|
| Age, mean (range) | 40.1 (20–64) |
| Gender | |
| Male | 184 (69.2) |
| Female | 82 (30.8) |
| Clinical Site | |
| Site 1 | 157 (59.0) |
| Site 2 | 109 (41.0) |
| Specialty of Buprenorphine Prescriber | |
| Primary Care | 187 (70.3) |
| Psychiatry | 79 (29.7) |
| Main reason for entry into federally qualified health center | |
| Buprenorphine maintenance treatment | 214 (80.5) |
| Primary care treatment | 52 (19.5) |
| Co-morbidities (based on ICD-9 coding in electronic medical record) | |
| HIV infection | 29 (10.9) |
| HCV infection | 159 (59.8) |
| HBV infection | 3 (1.1) |
| Metabolic disorder (diabetes, hypertension, hyperlipidemia, coronary artery disease) | 94 (35.3) |
| Pulmonary disorder (chronic obstructive pulmonary disorder, asthma) | 47 (17.7) |
| Mood disorder (depression, bipolar disorder, anxiety disorder) | 191 (71.8) |
| Prescribed medication for comorbid psychiatric condition | 173 (65.0) |
ICD-9: International Classification of Diseases, 9th Revision